Severe thyrotoxicosis induced by tislelizumab: a case report and literature review

Immune checkpoint inhibitors (ICIs) have made significant breakthroughs in the treatment of a variety of malignancies. As its use increases, the unique immune-mediated toxicity profile of ICls are becoming apparent. We report a case of immune-related endocrine adverse events (irAE) in a patient with...

Descripción completa

Detalles Bibliográficos
Autores principales: Huo, Liman, Wang, Chao, Ding, Haixia, Shi, Xuelian, Shan, Bin, Zhou, Ruoying, Liang, Ping, Hou, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578961/
https://www.ncbi.nlm.nih.gov/pubmed/37849819
http://dx.doi.org/10.3389/fonc.2023.1190491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578961/
https://www.ncbi.nlm.nih.gov/pubmed/37849819
http://dx.doi.org/10.3389/fonc.2023.1190491

Ejemplares similares